Efficacy of Amplification With Hearing Aids for Tinnitus Relief
NCT ID: NCT03716544
Last Updated: 2024-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2018-11-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Broadband Amplification as Tinnitus Treatment
NCT05271825
Effects of CI on Tinnitus and Its Symptoms
NCT05453019
Amplification and Tinnitus Masker Performance and Benefit for Adults With Hearing Loss and Tinnitus
NCT07298499
Auditory-somatosensory Stimulation to Alleviate Tinnitus
NCT02974543
Mechanism Research of Tinnitus Based on Electroencephalogram and Acoustic Therapy Intervention
NCT04449237
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Waiting list control group
There will be no treatment for 12 months.
No interventions assigned to this group
Hearing aid group
Participants will receive amplification with hearing aids. Bilateral open-fit hearing aids will be fitted. Participants will be required to use the hearing aids for at least 2 hours daily for 12 months.
Amplification with hearing aid
Use of hearing aids
Customized music group
Customized music according to participants hearing level will be made available in an iPod. The iPod will deliver ear-specific therapeutic sound for asymmetrical hearing profile. Participants will have to listen to the therapeutic sound at a comfortable volume for two hours daily for 12 months.
Customized music
Customized music delivered via an iPod
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amplification with hearing aid
Use of hearing aids
Customized music
Customized music delivered via an iPod
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* can provide written informed consent
* have a diagnosis of subjective tinnitus, i.e., the tinnitus can only be heard by the patient and there is no acoustic source
* a tinnitus duration of more than one year
* have pure-tone average between 20 and 40 dB HL
* have bilateral symmetrical hearing loss (i.e. difference less than 15 dB)
* have at least a medium level of distress caused by tinnitus as indicated with total scores above 30 on the TQ-CH
* are committed to complete the 12-month follow-up
Exclusion Criteria
* received other forms of tinnitus treatments within three months before the baseline assessment session
* any history suggestive of psychiatric illness
* psychological distress or depression as indicated with total scores at or above 15 on the Cantonese HADS
* current hearing aid users
* inability to complete the study as revealed by the medical reports
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Education University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
KAM Chi Shan Anna
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna CS KAM, AuD
Role: PRINCIPAL_INVESTIGATOR
The Education University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Education University of Hong Kong
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kam ACS. Efficacy of Amplification for Tinnitus Relief in People With Mild Hearing Loss. J Speech Lang Hear Res. 2024 Feb 12;67(2):606-617. doi: 10.1044/2023_JSLHR-23-00031. Epub 2024 Jan 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RGC18100117
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.